Source: Eur Respir J 2007; 30: 848-856
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Loven J., Svitacheva N., Jerre A., Miller-Larsson A., Korn S. H.. Anti-inflammatory activity of β2-agonists in primary lung epithelial cells is independent of glucocorticoid receptor. Eur Respir J 2007; 30: 848-856

Member's Comments

No comment yet.

Related content which might interest you: Importin-7 knockdown reduces corticosteroid induced glucocorticoid receptor nuclear localisation and suppression of IL-1beta induced CXCL8 Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells Source: Eur Respir J 2001; 17: 1070-1077 Year: 2001 SiRNA mediated growth factor receptors inhibition in A549 cell model of lung cancer gene therapy: insulin-like growth factor-I receptor (IGF-R1) blockade produces changes that potentially induce anti-tumor immunity Source: Annual Congress 2008 - Biology in thoracic tumours Year: 2008 Potential role of short hairpin RNA targeting epidermal growth factor receptor in growth and sensitivity to drugs of human lung adenocarcinoma cells Source: Eur Respir J 2006; 28: Suppl. 50, 325s Year: 2006 Anti-inflammatory efficacy of formoterol via transrepressive mechanisms is independent of the glucocorticoid receptor in human bronchial epithelial cells Source: Eur Respir J 2004; 24: Suppl. 48, 128s Year: 2004 Epidermal growth factor receptor (EGFR) overexpression in human bronchial epithelial cells amplifies IL-8 release provoked by cigarette smoke and bacterial surrogates Source: Eur Respir J 2005; 26: Suppl. 49, 441s Year: 2005 Synergistic action of formoterol on budesonide-generated decrease of proteoglycan production by activated lung fibroblasts is mediated via β-adrenergic receptor and is dependent on glucocorticoid receptor Source: Eur Respir J 2004; 24: Suppl. 48, 345s Year: 2004 Anti-inflammatory effect of adenovirus-mediated IκBα overexpression in respiratory epithelial cells Source: Eur Respir J 2001; 18: 801-809 Year: 2001 The natural anticoagulant activated protein C inhibits the expression of platelet-derived growth factor in the lung Source: Eur Respir J 2002; 20: Suppl. 38, 571s Year: 2002 Interferon gamma decreases interleukin-8 production and neurokinin-1 receptor expression in lung alveolar epithelial cells Source: Eur Respir J 2001; 18: Suppl. 33, 80s Year: 2001 Corticosteroid effects on cell signalling Source: Eur Respir J 2006; 27: 413-426 Year: 2006 Human lung fibroblasts secrete nerve growth factor: effect of inflammatory cytokines and glucocorticoids Source: Eur Respir J 2001; 18: 115-121 Year: 2001 Targeted therapy in nonsmall cell lung cancer Source: Eur Respir Mon; 2009: 44: 284–298 Year: 2009 ErbB receptor regulation by dexamethasone in mouse type II epithelial cells Source: Eur Respir J 2006; 28: 1117-1123 Year: 2006 Endothelin receptor B (ETBR) dependent GM-CSF mRNA stabilization explains the higher efficacy of bosentan vs. ambrisentan in the reduction of GM-CSF release from human airway smooth muscle cells (HASMCs) Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011 Levels of plasma tumour necrosis factor and soluble tumour necrosis factor receptor in patients with COPD and its relation to glucocorticoid receptor levels Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 Pharmacological inhibition of epidermal growth factor receptor modulates cigarette smoke-induced CXCL8 release but not VEGF release Source: Annual Congress 2012 - Basic and translational studies in COPD Year: 2012 Expression of angiogenic growth factors and stromal cell derived factor-1/CXC chemokine receptor 4 (SDF-1/CXCL12 – CXCR4) biological axis in idiopathic pulmonary fibrosis: a lung tissue study Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis Year: 2008 The perxisome proliferator-activated receptor gamma agonist, rosiglitazone, inhibits IL-8 synthesis by airway epithelial cells stimulated with monocyte-derived microparticles Source: Annual Congress 2007 - Epithelial networks in the airways Year: 2007 Generation and activation of myeloid derived suppressor cells using prostaglandin E2 and EP receptor agonists in vitro Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019